TGFB1 and cancer: As both fibroblast and CAFs demonstrate dependence on TGF-β signalling and stimulation by chemotherapy, modulation of TGF-β signalling in post-chemotherapy-treated cancer patients is an attractive notion and may lead to increased patient benefit while reducing co-morbidities [96,106].